HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug hope for kids with lung damage after transplant
Disease control TerminatedThis study tested the drug ruxolitinib for children and adults who develop early lung problems after a stem cell transplant. Lung issues like bronchiolitis obliterans are common and often found too late. The goal was to see if adding ruxolitinib to standard treatment could revers…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated May 26, 2026 10:08 UTC
-
New antibiotic tackles tough infections in vulnerable cancer patients
Disease control TerminatedThis study tested the antibiotic ceftolozane-tazobactam in 17 people with blood cancers or who had a stem cell transplant and developed a serious Pseudomonas infection. The goal was to see if the drug could help patients survive and clear the infection within 30 days. Participant…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 20, 2026 11:56 UTC